Segment Information - Financial Information by Segment (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) segment	Jun. 30, 2022 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			2
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	$ 2,563,226	$ 2,500,015	$ 5,086,075	$ 4,906,967
Operating income:	10,839	75,085	20,646	136,144
Acquisition-related charges and intangible amortization	(22,203)	(37,276)	(44,392)	(79,410)
Exit and realignment charges	(28,963)	(1,214)	(44,637)	(2,896)
Depreciation and amortization:	72,062	73,161	142,988	97,286
Consolidated capital expenditures	49,489	54,738	100,979	65,699
Operating Segments
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	2,563,226	2,500,015	5,086,075	4,906,967
Operating Segments | Products & Healthcare Services
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	1,930,723	1,927,388	3,846,212	4,061,429
Operating income:	2,940	61,243	4,761	150,325
Depreciation and amortization:	18,772	19,209	37,338	38,203
Consolidated capital expenditures	6,602	18,418	12,934	29,061
Operating Segments | Patient Direct
Segment Reporting, Revenue Reconciling Item [Line Items]
Net revenue	632,503	572,627	1,239,863	845,538
Operating income:	59,065	52,332	104,914	68,125
Depreciation and amortization:	53,290	53,952	105,650	59,083
Consolidated capital expenditures	42,887	36,320	88,045	36,638
Segment Reconciling Items
Segment Reporting, Revenue Reconciling Item [Line Items]
Acquisition-related charges and intangible amortization	(22,203)	(37,276)	(44,392)	(79,410)
Exit and realignment charges	$ (28,963)	$ (1,214)	$ (44,637)	$ (2,896)